Stocks · News reference
Barclays Maintains Overweight on MetLife, Raises Price Target to $111
Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $97 to $111.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $110
Wells Fargo analyst Wesley Carmichael maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $109 to $110.
Transcript: MetLife Q2 2026 Earnings Conference Call
On Thursday, MetLife (NYSE:MET) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our
Mizuho Maintains Outperform on MetLife, Lowers Price Target to $109
Mizuho analyst Yaron Kinar maintains MetLife (NYSE:MET) with a Outperform and lowers the price target from $112 to $109.